Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Bullboard (TSXV:CLAS.H)

View:
Post by Red~Oneon Sep 12, 2022 4:08pm

You 2 should get a room

DREWDrew here click on..okay?
Comment by PTBaileyon Sep 12, 2022 12:38pm

RE:Mrs Bailey

I have not.
Post by polo22on Sep 12, 2022 12:32pm

Mrs Bailey

Have you been able to reach Drew lately...and if you did  what  did he had to say?
Comment by PTBaileyon Sep 12, 2022 11:45am

RE:Mrs Bailey

I have no idea and my only optimism is that have not announced they are shutting down.
Post by polo22on Sep 12, 2022 9:55am

Mrs Bailey

What is going on....!!!
Comment by PTBaileyon Sep 11, 2022 11:53am

RE:AND WHAT HAVE WE HERE. BOB'S NEW VENTURE?

Address not found Your message wasn't delivered to rfarrell@freseniusnw.combecause the domain freseniusnw.com couldn't be found. Check for typos or unnecessary ...more  
Post by polo22on Sep 11, 2022 9:14am

Any hope left….

Good morning Mrs Bailey... What's your thinking this morning ...,.
Post by losingmyshirton Sep 10, 2022 10:26am

CALL HIM (415) 203-9463. HE HAS YOUR MONEY.

BUT HE PLACED ALL OF YOUR MONEY IN HIS NEW VENTURE. ASK HIM FOR YR MONEY BACK.  (415) 203-9463
Post by losingmyshirton Sep 10, 2022 10:15am

AND WHAT HAVE WE HERE. BOB'S NEW VENTURE?

https://fonmarketplace.com/high-net-worth-indiv/robert-e-farrell/ LIKE AN EEL. CALL BOB RIGHT AWAY AND ASK IF IT'S TRUE
Post by losingmyshirton Sep 10, 2022 10:11am

GREAT LINK ABOUT BOB AS A LAWYER. EX LAWYER I MEAN

https://apps.calbar.ca.gov/attorney/Licensee/Detail/91334 Robert Edward Farrell #91334 License Status: Not Eligible to Practice Law Address: 41 Thunderbird Dr, Novato, CA ...more  
Post by Red~Oneon Sep 09, 2022 12:30pm

Long Covid news ......Not CLAS

Todos Medical, through its majority owned subsidiary 3CL Pharma, has commercialized Tollovid™, the 3CL protease inhibitor immune support dietary supplement with recent data in acute and Long ...more  
Comment by PTBaileyon Sep 08, 2022 3:28pm

RE:" London Bridge Has Fallen " !

Pretty much only people over 80 would remember when she became queen. Amazng legacy no matter what you think of the monarchy.
Post by HighSkies2019on Sep 08, 2022 1:43pm

" London Bridge Has Fallen " !

Queen Elizabeth has passed. May she rest in Peace .
Post by Red~Oneon Sep 08, 2022 11:27am

ultra-high concentration nitric oxide

.....ultra-high concentration nitric oxide ("UNO") therapy of more than 10,000 parts per million (''ppm'') in the treatment of solid metastatic tumours." Link
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities